Standard BioTools Inc. (NASDAQ: LAB) (the 'Company” or 'Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025.

Comprehensive VAX-31 Adult Phase 3 Clinical Program, Finalized in Consultation and Alignment with FDA, Advances with Three Phase 3 Studies Underway to Support Planned BLA Submission ...

Apple plans to start manufacturing the Mac mini in the United States later this year, the company announced today, as part of ...

Inside a Michigan company where defense-level engineering, American steel, and seasoned pit knowledge are reshaping how ...

ZIBO CITY, SHANDONG PROVINCE, CHINA, February 12, 2026 /EINPresswire.com/ -- The global liquid ring vacuum pump market ...

How China’s Leading Activewear Manufacturers are Shaping the Future of Sports Fashion and Performance. CALIFORNIA, CA, UNITED STATES, February 13, ...

HUZHOU CITY, ZHEJIANG PROVINCE, CHINA, February 10, 2026 /EINPresswire.com/ -- The global woodworking industry has ...

Discover how transfer pricing and standard costs guide internal pricing strategies, help in budgeting, and meet regulatory compliance for better financial decision-making.

Driving Innovation and Sustainability in the Sanitary Napkin Market with Advanced Manufacturing Solutions CALIFORNIA, ...

LyondellBasell Industries, one of the largest plastics, chemicals, and refining companies globally, maintains a strong presence in polypropylene sheet manufacturing. Their product portfolio includes ...

Illumina Inc. (Nasdaq: ILMN), a genomics and molecular diagnostics company headquartered in San Diego, closed in late January on its acquisition of Boulder-based biotech firm SomaLogic Inc.